Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
3.520
+0.780 (28.47%)
At close: Mar 9, 2026, 4:00 PM EDT
3.360
-0.160 (-4.55%)
After-hours: Mar 9, 2026, 6:37 PM EDT
Polaryx Therapeutics Market Cap
Polaryx Therapeutics has a market cap or net worth of $166.65 million as of March 9, 2026.
Market Cap
166.65M
Enterprise Value
159.96M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since February 2, 2026, Polaryx Therapeutics's market cap has decreased from $1.66B to $166.65M, a decrease of -89.94%. That is a compound annual growth rate of -100.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 129.72M | -92.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |
| Adagene | 133.85M |
| Oramed Pharmaceuticals | 130.75M |
| Spero Therapeutics | 129.58M |
| Cardiff Oncology | 128.53M |
| Aardvark Therapeutics | 127.37M |
| Alpha Cognition | 125.89M |